- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2015
- Public Summary Document (PSD) July 2015 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2015 PBAC Meeting - Word
Netupitant and palonosetron – July 2015
Netupitant and palonosetron; netupitant 300 mg + palonosetron 0.5 mg, 1; Akynzeo®
Last updated
1 November 2015